Failure of Intravesical Interferon-Alfa-2b for the Treatment of Patients with Superficial Bladder Cancer Previously Failing Intravesical BCG Therapy

Author： Hudson M.A.   Ratliff T.L.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.1, Iss.3, 1995-05, pp. : 115-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacillus calmete-guerin plus interferon- 2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

By Lam J.S.   Benson M.C.   O'Donnell M.A.   Sawczuk A.   Gavazzi A.   Wechsler M.H.   Sawczuk I.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 354-360

Elsevier

Access to resources Recommend Favorite

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

By Yamashita M.   Rosser C.J.   Zhou J.H.   Zhang X.Q.   Connor R.J.   Engler H.   Maneval D.C.   Karashima T.   Czerniak B.A.   Dinney C.P.   Benedict W.F.   Hsieh J.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 313-314

Elsevier

Access to resources Recommend Favorite

Maintenance Therapy with Intravesical Bacillus Calmette-Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

By Muto Satoru   Nakajima Akiko   Horiuchi Akira   Inoue Masayuki   China Toshiyuki   Saito Keisuke   Isotani Shuji   Hisasue Shin-ichi   Yamaguchi Raizo   Ide Hisamitsu   Horie Shigeo  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

By Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite